Acorda Therapeutics (ACOR) Tops Q3 EPS by 5c, Offers Guidance
Tweet Send to a Friend
Acorda Therapeutics (NASDAQ: ACOR) reported Q3 EPS of ($0.46), $0.05 better than the analyst estimate of ($0.51). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
